Flow Forward: Advanced Biomedical Cytometry

Description

Are your lab protocols quietly undermining your immunotherapy data?

Join our upcoming talk on April 30th, 2026 at 10:30am EST to discover how minimal sample perturbation assays are transforming cancer research and why ultra-precise technique is now a decisive factor in personalizing treatment.

Key takeaways:

· Why minimal perturbation protocols are non-negotiable for accurate flow cytometry

· The clinical significance of the PD-L1 index on circulating MDSCs

· How this index correlates with poor patient survival – and how it can guide better treatment decisions

Essential for Immunologists, Oncologists, Clinical Researchers, and Lab Directors working at the frontier of precision oncology.

Register now to secure your spot!